we are dedicated to our mission of striving to extend survival in some of the most aggressive forms of cancer.

We joined Novocure for the opportunity to make a difference in cancer. Establishing, building and growing an innovative company to provide patients with a new cancer treatment modality demands drive, commitment and an unwavering focus on the scientific evidence to keep moving forward regardless of the obstacles or resistance that may be encountered. We are passionate about advancing our business and further developing our science to bring our therapy to all patients who may benefit around the world.

Bill Doyle
Executive Chairman
Asaf Danziger
Chief Executive Officer
https://www.novocure.com/wp-content/uploads/2021/11/aa793d50eb522e6fb1316d1ad2a8327b0562e2fc-1024x684.png
Ashley Cordova, Chief Financial Officer

corporate officers and executive leadership

William F. Doyle
Executive Chairman
Asaf Danziger
Chief Executive Officer
Ely Benaim, M.D.
Chief Medical Officer
Barak Ben-Arye
General Counsel
William Burke
Chief Human Resources Officer
Ashley Cordova
Chief Financial Officer
Wilco Groenhuysen
Chief Operating Officer
Frank Leonard
Chief Development Officer
Pritesh Shah
Chief Commercial Officer
Uri Weinberg, M.D., Ph.D.
Chief Science Officer
https://www.novocure.com/wp-content/uploads/2021/11/e3014fdbb8435bdaeb4f74e67b649087e8f5694b-1024x684.png

contact Novocure

Thank you for your interest in Novocure. Please click the link below, complete and submit the contact form, or use the company directory to find a specific business unit or location.

contact Novocure